Skip to main content

Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer?

Comparison of mucosal lesions in the residual stomach before and after Helicobacter pylori eradication

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Background and aims

After partial gastrectomy, the mucosa of the residual stomach usually undergoes severe changes, and these lesions are known to be pre-cancerous. Recently, Helicobacter pylori has been highlighted as an agent that induces such mucosal alterations. In the present study, we evaluated whether eradication of H. pylori reduced the risk of carcinogenesis.

Patients and methods

The subjects were 12 patients who underwent distal gastrectomy with Billroth I anastomosis for early gastric cancer and were positive for H. pylori. We performed endoscopy and biopsy both before and after H. pylori eradication therapy to assess changes in the gastric mucosa.

Results

After eradication therapy, no mucosal edema or erythema was detected. On histological examination, mononuclear cell infiltration had decreased and there was complete absence of neutrophil infiltration. The Ki-67 labeling index and the tissue IL-8 level had also decreased significantly, compared with before eradication.

Conclusion

Before H. pylori eradication, the mucosa of the residual stomach may be at high risk of carcinogenesis due to induction of mucosal damage and active gastritis by H. pylori. Such changes were almost completely normalized by eradication therapy, so the eradication of H. pylori may reduce the risk of H. pylori-associated carcinogenesis in patients who have undergone gastrectomy for early gastric cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6a–c
Fig. 7
Fig. 8a–c
Fig. 9

Similar content being viewed by others

References

  1. Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK (1991) Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 325:1127–1131

    CAS  PubMed  Google Scholar 

  2. Nomura A, Stemmermann GN, Chyou PH, Kato I, Perez-Perz GI, Blaser MJ (1991) Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132–1136

    CAS  PubMed  Google Scholar 

  3. Asaka M, Kimura T, Kato M, Kudo M, Miki K, Ogoshi K, Kato T, Tatsuta M, Graham DY (1994) Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer 73:2691–2694

    CAS  PubMed  Google Scholar 

  4. Fukuda H, Saito D, Hayashi S, Hisai H, Ono H, Yoshida S, Oguro Y, Noda T, Sato T, Katoh M, Terada M, Sugimura T (1995) Helicobacter pylori Infection, serum pepsinogen level and gastric cancer: a case-control study in Japan. Jpn J Cancer Res 86:64–71

    CAS  PubMed  Google Scholar 

  5. Kikuchi S, Wada O, Nakajima T, Nishi T, Kobayashi O, Konishi T, Inaba Y and the research group on prevention of gastric carcinoma among young adults (1995) Serum anti-Helicobacter pylori antibody and gastric carcinoma among young adults. Cancer 75:2789–2793

    CAS  PubMed  Google Scholar 

  6. International Agency for Research on Cancer (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC monographs on the evaluation of carcinogenic risks to humans. IARC Scientific Publication no 61, Lyon, pp 177–240

  7. Uemura N, Mukai T, Okamoto S, Yamaguchi S, Mashiba H, Taniyama K, Sasaki N, Haruma K, Sumii K, Kajiyama G (1997) Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 6:639–642

    CAS  PubMed  Google Scholar 

  8. The European Helicobacter pylori study group (1997) Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 41:8–13

    PubMed  Google Scholar 

  9. Langhans P, Bues M, Bunte H (1984) Morphological changes in the operated stomach under the influence of duodenogastric reflux. Clinical follow-up over 20 years. Scand J Gastroenterol 19 [Suppl 92]:145–148

    Google Scholar 

  10. Weinstein WM, Buch KL, Elashoff J, Reedy T, Tedesco FJ, Samloff IM, Ippoliti AF (1985) The histology of the stomach in symptomatic patients after gastric surgery: a model to assess selective patterns of gastric mucosal injury. Scand J Gastroenterol 20 [Suppl 109]:77–89

  11. Domellof L (1979) Gastric carcinoma promoted by alkaline reflux gastritis—with special reference to bile and other surfactants as promoters of post-operative gastric cancer. Med Hypotheses 554:63–76

    Google Scholar 

  12. Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process—first American Cancer Society award lecture on cancer epidemiology and prevention. Cancer Res 52: 6735–6740

    CAS  PubMed  Google Scholar 

  13. Safatle-Ribeilo AV, Ribeilo U Jr, Clarke MR, Sakai P, Ishioka S, Garido AB Jr, Gama-Rodrigues J, Safatle NF, Reynolds JC (1999) Relationship between persistence of Helicobacter pylori and dysplasia, intestinal metaplasia, atrophy, inflammation, and cell proliferation following partial gastrectomy. Dig Dis Sci 2:243–252

    Article  Google Scholar 

  14. Kurihara N, Kubota T, Ohtani Y, Kumai K, Kitazima M (1995) High incidence of Helicobacter pylori infection detected serologically in the residual stomach by gastric cancer. Oncol Rep 4:103–106

    Google Scholar 

  15. Katsube T, Ogawa K, Hamaguchi K, Murayama M, Konno S, Shimakawa T, Naritaka Y, Yagaw H, Kajiwara T, Aiba M (2002) Prevalence of Helicobacter pylori in the residual stomach after gastrectomy for gastric cancer. Hepatogastroenterology 49:128–132

    PubMed  Google Scholar 

  16. Hiker E, Domske W, Stoll R (1996)13C-urea breath test for detection of Helicobacter pylori and its correlation with endoscopic and histologic findings. J Physiol Pharmacol 47:79–90

    PubMed  Google Scholar 

  17. Yamamoto Y, Kouda M, Abe K. Sakurabayashi S, Sezai S, Hirano M, Oka H (1995) Detection of Helicobacter pylori by culture and the 13C-urea breath test using an automated breath 13C analyzer. JSGE 92:1839–1845

    CAS  Google Scholar 

  18. Graham PD, Klein PD, Evance DJ Evance DG, Alpert LC, Opekum AR, Boutton TW (1987) Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet i:1174–1177

    Article  Google Scholar 

  19. Klein PD, Malaty HM, Martin RF, Graham KS, Genta RM, Graham DY (1996) Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C-urea breath test. Am J Gastroenterol 91:690–694

    CAS  PubMed  Google Scholar 

  20. Ohara S, Kato M, Asaka M, Toyota T (1998) Studies of 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan. J Gastroenterol 33:6–13

    CAS  Google Scholar 

  21. Lotterler E, Ludtke FE, Tegeler R, Lepsien G, Bauer FE (1993) The 13C-urea breath test-detection of Helicobacter pylori infection in patients with partial gastrectomy. Z Gastroenterol 31:115–119

    Google Scholar 

  22. American Digestive Health Foundation (1997) The report of the digestive health initiative international update conference on Helicobacter pylori. Gastroenterology 113:4–8

    Google Scholar 

  23. Tytgat GNJ (1991) The Sydney system: endoscopic division. Endoscopic appearance in gastritis/duodenitis. J Gastroenterol Hepatol 6:223–234

    CAS  PubMed  Google Scholar 

  24. Dixson MF, Genta RM, Yardley JH, Crrea P (1996) Classification and grading of gastritis. The update Sydney system. Am J Surg Pathol 20:1161–1181

    Article  CAS  PubMed  Google Scholar 

  25. Bradford MA (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72:248–254

    Article  CAS  PubMed  Google Scholar 

  26. Endo I, Sugiyama M, Yamamoto T, Katamura H (1992) The role of Helicobacter pylori on gastritis occurring in the gastric stump. Ther Res 13:2653–2656

    Google Scholar 

  27. Kiyozaki H, Nei J, Hayase M (1993) The role of Helicobacter pylori in gastritis after distal partial gastrectomy. Gastroenterol Endosc 35:9–14

    Google Scholar 

  28. Nagahata Y, Kawakita N, Azumi Y, Numata N, Yano M, Saitoh Y (1996) Etiological involvement of Helicobacter pylori in reflux gastritis after gastrectomy. Am J Gastroenterol 91:2130–2134

    CAS  PubMed  Google Scholar 

  29. Kurihara N, Kubota T, Hayashi N, Ishizuka H, Hoshiya Y, Sakurai Y, Yoshida M, Murayama Y, Ohtani Y, Kumai H, Kitazima M (1995) Gastritis in the residual stomach and Helicobacter pylori infection. Gastroenterol Endosc 37:2441–2445

    Google Scholar 

  30. Leivonen MK, Haglund CH, Nordling SFA (1997) Helicobacter pylori infection after partial gastrectomy for peptic ulcer and its role in relapsing disease. Eur J Gastroenterol Hepatol 9:371–374

    CAS  PubMed  Google Scholar 

  31. Miwa H, Hirose M, Kikuchi S, Terai T, Iwazaki R, Kobayashi O, Takei Y, Ogihara T, Sato N (1999) How useful is the detection kit for antibody in urine (URINELISA) in clinical practice? Am J Gastroenterol 94:3460–3463

    Article  CAS  PubMed  Google Scholar 

  32. Buruk F, Berberoglu U, Pak I, Aksaz E, Celen O (1993) Gastric cancer and Helicobacter pylori infection. Br J Surg 80:378–379

    CAS  PubMed  Google Scholar 

  33. Sipponen P, Seppala K (1992) Gastric carcinoma: failed adaptation to Helicobacter pylori. Scand J Gastroenterol 27:33–38

    PubMed  Google Scholar 

  34. Sipponen P, Hyvarinen H (1993) Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol 28:3–6

    Google Scholar 

  35. Correa P, Ruiz B, Shi TY, Janney A, Sobhan M, Torrado J, et al (1994) Helicobacter pylori and nucleolar organizer regions in the gastric antral mucosa. Am J Clin Pathol 101:656–660

    CAS  PubMed  Google Scholar 

  36. Fan XG, Kelleher D, Fan XL, Xia HX, Keeling PWN (1996) Helicobacter pylori increases proliferation of gastric epithelial cells. Gut 38:19–22

    CAS  PubMed  Google Scholar 

  37. Hibi K, Mitomi H, Koizumi W, Tanabe S, Saigenji K, Okayasu I (1997) Enhanced cellular proliferation and p53 accumulation in gastric mucosa chronically infected with Helicobacter pylori. Am J Clin Pathol 108:26–34

    CAS  PubMed  Google Scholar 

  38. Lynch DAF, Mapstone NP, Clarke AMT, Jackson P, Dixon MF, Quirke P (1995) Cell proliferation in the gastric corpus in Helicobacter pylori associated gastritis and after gastric resection. Gut 36:351–353

    CAS  PubMed  Google Scholar 

  39. Leivonen M, Nordling S, Haglund C(1997) Does Helicobacter pylori in the gastric stump increase the cancer risk after certain reconstruction types? Anticancer Res 17:3893–3896

    CAS  PubMed  Google Scholar 

  40. Blaser MJ (1992) Hypotheses on the pathogenesis and natural history of Helicobacter pylori -induced inflammation. Gastroenterology 102:720–727

    CAS  PubMed  Google Scholar 

  41. Cover TL, Blaser MJ (1992) Helicobacter pylori and gastroduodenal disease. Annu Rev Med 43:135–145

    Article  CAS  PubMed  Google Scholar 

  42. Baggiolini M, Walz A, Kunkel SL (1989) Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045–1049

    CAS  PubMed  Google Scholar 

  43. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K (1991) Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol 9:617–648

    CAS  PubMed  Google Scholar 

  44. Davies GR, Banatvala N, Collins CE, Sheaff MT, Abdi Y, Clements L, Rampton DS (1994) Relationship between infective load of Helicobacter pylori and reactive oxygen metabolite production in antral mucosa. Scand J Gastroenterol 29:419–424

    CAS  PubMed  Google Scholar 

  45. Ohkusa T, Kumagai J, Tanizawa T (1998) Changes in endoscopic features of H. pylori-related gastritis with follow-up over a year after eradication of H. pylori, measured according to the Sydney system. Gastroenterol Endosc 10:1001–1008

    Google Scholar 

  46. Kawakita N, Nagahata Y, Azumi Y, Wada T, Numata N, Saitoh Y (1995) Residual gastritis after gastrectomy and Helicobacter pylori—Its clinical significance. Jpn J Gastroenterol 92:862–869

    CAS  Google Scholar 

  47. Rauws EJ, Langenberg W, Houthoff HJ, Zanen HC, Tygat GN (1988) Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33–40

    CAS  PubMed  Google Scholar 

  48. Murakami K, Fujioka T, Kodama R, Kubota T, Tokieda M, Nasu M (1997) Helicobacter pylori infection accelerates human gastric mucosal cell proliferation. J Gastroenterol 32:184–188

    CAS  PubMed  Google Scholar 

  49. Shijou Y (1998) Gastric epithelial cell proliferation before and after eradication therapy of Helicobacter pylori. An immunohistochemical study. J Tokyo Women Med Univ 68:123–130

    Google Scholar 

  50. Brenes F, Ruiz B, Correa P, Hunter F, Rhamakrishnan T, Fontham E, Shi TY (1993) Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol 88:1870–1875

    CAS  PubMed  Google Scholar 

  51. Zang QB, Dawodu JB, Husain A, Etohli G, Gemmell CG, Russell RI (1997) Association of antral mucosal levels of interleukin-8 and reactive oxygen radicals in patients infected with Helicobacter pylori. Clin Sci 92:69–73

    PubMed  Google Scholar 

  52. Ito M, Haruma K, Kamada T, Mihara M, Kim S, KItadai Y, Sumii M, Tanaka S, Yoshihara M, Chayama K (2002) Helicobacter pylori eradication therapy improves atrophic gastritis and intestinal metaplasia: a 5-year prospective study of patients with atrophic gastritis. Alimental Pharmacol Ther 16:1449–1456

    Article  CAS  Google Scholar 

  53. Nordone G, Staibano S, Rocco A, Mezza E, D’Armiento FP, Insabato L, Coppola A, Salvatore G, Lucariello A, Fugura N, De Rosa G, Budillon G (1999) Effect of Helicobacter pylori infection and its eradication on cell proliferation, DNA status, and oncogene expression in patients with chronic gastritis. Gut 44:789–799

    PubMed  Google Scholar 

  54. Murakami K, Fujioka T, Okimoto T, Mitsuishi Y, Oda T, Nishizono A, Nasu M (1999) Analysis of p53 gene mutations in Helicobacter pylori -associated gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol 34:474–477

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K. Ogawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hamaguchi, K., Ogawa, K., Katsube, T. et al. Does eradication of Helicobacter pylori reduce the risk of carcinogenesis in the residual stomach after gastrectomy for early gastric cancer?. Langenbecks Arch Surg 389, 83–91 (2004). https://doi.org/10.1007/s00423-003-0451-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-003-0451-x

Keywords